Market Overview

UPDATE: Jefferies Raises PT on Humana Ahead of 2Q Earnings Report

Share:
Related HUM
Portfolio Manager Minyi Chen On Why Certain Companies Are Likely M&A Targets
Leon Cooperman's Omega Advisors Sells Apple, Gilead; Buys Humana, GM And IBM
Be Ready To Get A Piece Of PayPal - Cramer's Mad Money (5/21/15) (Seeking Alpha)

In a report published Wednesday, Jefferies analyst David Windley reiterated a Buy rating on Humana (NYSE: HUM), and raised the price target from $95.00 to $98.00.

In the report, Jefferies noted, “We expect MCOs to report 2Q earnings upsides. MCO commentary suggests utilization remains favorable, corroborated by Tenet's weak inpatient volumes and ISRG's weak capital equipment sales. We also highlight hot topics and headlines ahead of a flurry of important events over the next several months. AET remains our top MCO pick. We are modestly raising PTs for Diversifieds (still trading at a discount) on more stable outlooks.”

Humana closed on Tuesday at $85.18.

Latest Ratings for HUM

DateFirmActionFromTo
May 2015Sterne AgeeDowngradesNeutralUnderperform
May 2015Leerink SwannMaintainsOutperform
May 2015OppenheimerMaintainsOutperform

View More Analyst Ratings for HUM
View the Latest Analyst Ratings

Posted-In: David Windley JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (HUM)

Around the Web, We're Loving...